Bayer shares have increased significantly after the us supreme court made a decision regarding a roundup cancer lawsuit. The decision appears to have alleviated a substantial financial burden on the company. The lawsuit had posed a major litigation risk, but its rejection has lifted uncertainty surrounding the company's financial obligations.